Drug Shortage Report for MYLAN-VALSARTAN
Report ID | 26715 |
Drug Identification Number | 02383543 |
Brand name | MYLAN-VALSARTAN |
Common or Proper name | VALSARTAN |
Company Name | MYLAN PHARMACEUTICALS ULC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | VALSARTAN |
Strength(s) | 160MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100BT |
ATC code | C09CA |
ATC description | ANGIOTENSIN II ANTAGONISTS, PLAIN |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2017-11-01 |
Actual start date | |
Estimated end date | |
Actual end date | 2017-11-01 |
Shortage status | Resolved |
Updated date | 2017-11-02 |
Company comments | Discontinued as per ID 20284 |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2017-11-02 | French | Compare |
v4 | 2017-11-02 | English | Compare |
v3 | 2017-11-02 | English | Compare |
v2 | 2017-10-23 | French | Compare |
v1 | 2017-10-23 | English | Compare |
Showing 1 to 5 of 5